3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Dermatologic
2
Thoracic
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Conditions
Nasopharyngeal Carcinoma
39
Squamous Cell Carcinoma of Head and Neck
17
Head and Neck Neoplasms
8
Recurrence
5
Nasopharyngeal Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Sarcoma
2
Oropharyngeal Neoplasms
2
Mouth Neoplasms
2
Carcinoma, Squamous Cell
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Sinonasal undifferentiated carcinoma
1
Salivary Gland Malignant Neoplasms
1
Pathologic Complete Response
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer
1
Locally Advanced Hypopharyngeal Carcinoma
1
Head and Neck Squamous Cell Cancer
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Interventions
pembrolizumab
35
Cetuximab
18
Gemcitabine
14
Nivolumab
13
Cisplatin
13
Paclitaxel
10
Carboplatin
9
Cyclophosphamide
7
cemiplimab
6
Fluorouracil
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Docetaxel
5
fludarabine
4
durvalumab
4
aldesleukin
4
Immune Checkpoint Inhibitors
4
Biopsy
4
fludarabine phosphate
3
Valproic Acid
3
Radiation
3
Interleukin-2
3
Drug Therapy
3
Bevacizumab
3
130-nm albumin-bound paclitaxel
3
tislelizumab
2
sintilimab
2
avelumab
2
apatinib
2
Tablets
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
toripalimab
×
Head & Neck
×
Clear all
NCT07423078
2026-04-13
WOLF
University of Pittsburgh
Phase 2
Recruiting
87 enrolled